日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rituximab for severe immune checkpoint inhibitor-related adverse events: a multicenter case series

利妥昔单抗治疗严重免疫检查点抑制剂相关不良事件:一项多中心病例系列研究

Hermabessiere, Stéphanie; Jauzelon, Benjamin; Marmain, Steven; Wauthier, Axelle; Witkowski Durand Viel, Philine; Castille, Elodie; Padern, Guillaume; Lamoureux, Anouck; Thomas, Quentin Dominique; Quantin, Xavier; Maria, Alexandre T J; Coustal, Cyrille

Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae

免疫检查点抑制剂诱发的神经系统并发症:一项全面的描述性病例系列研究揭示了长期后遗症的高风险

Plaçais, Léo; Michot, Jean-Marie; Champiat, Stéphane; Romano-Martin, Patricia; Baldini, Capucine; Joao, Maria Silva; Marabelle, Aurélien; Voisin, Anne-Laure; Not, Adeline; Labeyrie, Céline; Beaudonnet, Guillemette; Laparra, Ariane; Maria, Alexandre T J; Masseau, Agathe; Dehette, Stéphanie; Deleporte, Amélie; Echaniz-Laguna, Andoni; Denier, Christian; Adams, David; Lambotte, Olivier; Noel, Nicolas; Cauquil, Cécile

iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis

iNOS活性是间充质干细胞在实验性系统性硬化症中发挥治疗作用所必需的

Maria, Alexandre T J; Rozier, Pauline; Fonteneau, Guillaume; Sutra, Thibault; Maumus, Marie; Toupet, Karine; Cristol, Jean-Paul; Jorgensen, Christian; Guilpain, Philippe; Noël, Danièle

Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells

HOCl 诱发的系统性硬化症中的纤维化发展:间充质干细胞阻碍的多阶段过程

Alexandre T J Maria, Karine Toupet, Marie Maumus, Pauline Rozier, Marie-Catherine Vozenin, Alain Le Quellec, Christian Jorgensen, Danièle Noël, Philippe Guilpain